Who invested in Reunion Neuroscience

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$69Mraised across 1 round since 2025, from 1 source

Latest round: Venture, $69MMay 2025
Investors: 1

See who backed them

The rounds

May 2025
Venture$69M
- Novo Holdings
Source recordedSEC filing: $69M sold, first sale Jan 2024

Founders and team

From Reunion Neuroscience's own website: 22 on the team.

Dr. Sahil KirpekarPresident & Chief Executive Officer
Dr. Nathan BrysonChief Scientific Officer
Edward SmithChief Financial Officer
Mark TheeuwesChief Operating Officer
Brian ShusterBoard Member
Dr. Alan SchatzbergBoard Member
Dr. Anita H. ClaytonBoard Member
Dr. Ansbert GadickeBoard Member
Dr. Charles NemeroffBoard Member
Dr. Jerry RosenbaumBoard Member
Dr. Kristina DeligiannidisBoard Member
Dr. Manish AgarwalBoard Member
Dr. Matthew W. JohnsonBoard Member
Dr. Michael Van AmeringenBoard Member
Dr. Natalie SacksBoard Member
Dr. Peter HendricksBoard Member
Dr. Pini OrbachBoard Member
Dr. Rachel YehudaBoard Member

And 4 more on the team.

Everyone who backed them

Novo HoldingsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Reunion Neuroscience as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.